Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Feldman, Steven
Item TypeName
Academic Article The promise and challenge of new biological treatments for psoriasis: how do they impact quality of life?
Academic Article Etanercept improves the health-related quality of life of patients with psoriasis: results of a phase III randomized clinical trial.
Academic Article Intermittent dosing of biologics for psoriasis.
Academic Article Novel combination regimens: biologics and acitretin for the treatment of psoriasis-- a case series.
Academic Article Eligibility creep: a cause for placebo group improvement in controlled trials of psoriasis treatments.
Academic Article Conversion to positive tuberculosis test during etanercept treatment of psoriasis.
Academic Article Cost-effectiveness of biologic treatments for psoriasis based on subjective and objective efficacy measures assessed over a 12-week treatment period.
Academic Article Paradoxical effects of cost reduction measures in managed care systems for treatment of severe psoriasis.
Academic Article Psoriasis and its treatment with adalimumab.
Academic Article Comparing the lifetime risks of TNF-alpha inhibitor use to common benchmarks of risk.
Academic Article Message from the guest editor.
Academic Article Trends in older adult psoriasis outpatient health care practices in the United States.
Academic Article New treatments for psoriasis: which biologic is best?
Academic Article Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.
Academic Article Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics.
Academic Article Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: results from a randomized, controlled Phase III study.
Academic Article Utilization pattern of etanercept and its cost implications in moderate to severe psoriasis in a managed care population.
Academic Article Efficacy of systemic treatments for moderate to severe plaque psoriasis: systematic review and meta-analysis.
Academic Article Economic evaluation of biologic therapies for the treatment of moderate to severe psoriasis in the United States.
Academic Article Efficacy and safety of ustekinumab and etanercept for the treatment of psoriasis.
Academic Article Cost per responder analysis of ustekinumab and etanercept for moderate to severe plaque psoriasis.
Academic Article Infections associated with the use of tumor necrosis factor-a inhibitors in psoriasis.
Concept Tumor Necrosis Factor-alpha
Concept Receptors, Tumor Necrosis Factor
Academic Article Cost effectiveness of biologic therapies for plaque psoriasis.
Academic Article Safety and tolerability of tumor necrosis factor-a inhibitors in psoriasis: a narrative review.
Academic Article Topical antimicrobial acne treatment tolerability: a meaningful factor in treatment adherence?
Academic Article Advances in Psoriasis.
Academic Article Severe and acute complications of biologics in psoriasis.
Academic Article Can We Tell Patients That IL-23 and TNF-a Inhibition Are "Natural" Ways to Treat Psoriasis?
Academic Article Psoriasis therapy and aortic inflammation - translating statistical to clinical significance.
Search Criteria
  • Complement Factor H